Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02821702Completed
Open-label trial, sponsored by Sheba Medical Center. Primary endpoints: Anti-Mullerian Hormone at 6 months and Antral Follicle Count at 6 months. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02821702.